“…A recently developed methanol and acetic acid-based fixative, PAXgene (PAXgene Tissue Fix Container, Preanalytix GmbH, Hombrechtikon, Switzerland), works via a non-crosslinking mechanism. Studies involving multiple types of cancer have demonstrated that PAXgene-fixed, paraffin-embedded (PFPE) tissue yields adequate histomorphology in the majority of cases (i.e., comparable to FFPE, far better than frozen tissue) [ 4 , 5 , 6 , 7 , 8 , 9 , 10 ]. These studies also suggested PFPE is associated with improved DNA and RNA yield and quality compared to FFPE [ 6 , 7 , 8 , 9 , 10 , 11 ].…”